TP53 and cancer: Interestingly, a recent study of 18 cancer cell lines reported that mRNA splicing gene sets were enriched among genes whose basal expression correlated with sensitivity to PRMT5 inhibition, and indicated that expression of p53 pathway genes was not correlated with sensitivity19.